Literature DB >> 18259720

[Hymenoptera venom anaphylaxis and cardiovascular disease].

U R Müller1.   

Abstract

Preexisting cardiovascular disease may worsen the course of anaphylaxis. This is illustrated based on the example of Hymenoptera venom allergy. Fatal sting anaphylaxis is most often observed in elderly patients. During autopsy preexisting cardiovascular disease is frequently found. Preexisting cardiovascular disease in patients with anaphylaxis may also cause lasting morbidity, e.g. cerebral or myocardial infarction. Heart medications, notably beta-blockers und ACE-inhibitors may worsen the course of anaphylactic reactions due to their pharmacologic effects. Since cardiovascular diseases are much more frequent than anaphylaxis and these medications are very effective, these drugs cannot be substituted in patients with both diseases without a careful risk analysis. Epinephrine is the drug of first choice for treatment of anaphylaxis. It may however, especially following rapid intravenous administration, cause severe arrhythmias or myocardial infarction. Adrenaline should therefore preferably be given intramuscularly, or by slow intravenous infusion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18259720     DOI: 10.1007/s00105-008-1469-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   1.198


  20 in total

Review 1.  beta-Blocker therapy in heart failure: scientific review.

Authors:  JoAnne Micale Foody; Michael H Farrell; Harlan M Krumholz
Journal:  JAMA       Date:  2002-02-20       Impact factor: 56.272

Review 2.  Lessons for management of anaphylaxis from a study of fatal reactions.

Authors:  R S Pumphrey
Journal:  Clin Exp Allergy       Date:  2000-08       Impact factor: 5.018

3.  Studies of 400 Hymenoptera sting deaths in the United States.

Authors:  J H Barnard
Journal:  J Allergy Clin Immunol       Date:  1973-11       Impact factor: 10.793

4.  [Fatalities from insect stings in Switzerland 1978 to 1987].

Authors:  T Sasvary; U Müller
Journal:  Schweiz Med Wochenschr       Date:  1994-10-29

Review 5.  Diagnosis of Hymenoptera venom allergy.

Authors:  B M Biló; F Rueff; H Mosbech; F Bonifazi; J N G Oude-Elberink
Journal:  Allergy       Date:  2005-11       Impact factor: 13.146

6.  Myocardial infarction induced by coronary vasospasm after self-administration of epinephrine.

Authors:  R Saff; A Nahhas; J N Fink
Journal:  Ann Allergy       Date:  1993-05

7.  Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade.

Authors:  R L Jacobs; G W Rake; D C Fournier; R J Chilton; W G Culver; C H Beckmann
Journal:  J Allergy Clin Immunol       Date:  1981-08       Impact factor: 10.793

8.  Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis.

Authors:  John A TenBrook; Michael P Wolf; Stuart N Hoffman; Lanny J Rosenwasser; Marvin A Konstam; Deeb N Salem; John B Wong
Journal:  J Allergy Clin Immunol       Date:  2004-05       Impact factor: 10.793

9.  Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections.

Authors:  M J Hepner; D R Ownby; J A Anderson; M S Rowe; D Sears-Ewald; E B Brown
Journal:  J Allergy Clin Immunol       Date:  1990-09       Impact factor: 10.793

Review 10.  Risk assessment in anaphylaxis: current and future approaches.

Authors:  F Estelle R Simons; Anthony J Frew; Ignacio J Ansotegui; Bruce S Bochner; David B K Golden; Fred D Finkelman; Donald Y M Leung; Jan Lotvall; Gianni Marone; Dean D Metcalfe; Ulrich Müller; Lanny J Rosenwasser; Hugh A Sampson; Lawrence B Schwartz; Marianne van Hage; Andrew F Walls
Journal:  J Allergy Clin Immunol       Date:  2007-07       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.